Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$224,948
in 1 filing, $225K under 10b5-1 plans

Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McFarlane Neil F. −$225K President and CEO sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2015-04-21 Plooster Matthew R Director Conversion · Series C Convertible Preferred Stock −8,381 0
2015-04-21 Plooster Matthew R Director Conversion · Series A Convertible Preferred Stock −1,701,011 0
2015-04-21 Plooster Matthew R Director Conversion · Series B Convertible Preferred Stock −1,511,279 0
2015-04-21 Plooster Matthew R Director Conversion · Warrant to Purchase Series D Preferred Stock (right to buy) −384 $0.78 $300 0
2015-04-21 Plooster Matthew R Director Conversion · Warrant to Purchase Common Stock (right to buy) +51 51
2015-04-21 Mickle Travis C President & CEO Conversion +5,983 277,094
2015-04-21 Mickle Travis C President & CEO Conversion +96,288 96,288
2015-04-21 Mickle Travis C President & CEO Conversion · Series A Convertible Preferred Stock −527,093 0
2015-04-21 Mickle Travis C President & CEO Conversion · Series B Convertible Preferred Stock −6,203 0
2015-04-21 Mickle Travis C President & CEO Conversion · Series C Convertible Preferred Stock −51,332 0
2015-04-21 Mickle Travis C President & CEO Conversion · Series C Convertible Preferred Stock −44,873 0
2015-04-21 Mickle Travis C President & CEO Conversion · Series D Convertible Preferred Stock −137,541 0
2015-04-21 Mickle Travis C President & CEO Conversion · Warrant to Purchase Series D Preferred Stock (right to buy) −32,371 $0.78 $25K 0
2015-04-21 Mickle Travis C President & CEO Conversion · Warrant to Purchase Common Stock (right to buy) −4,316 4,316
2015-04-21 Guenther Sven Exec VP R&D Conversion +23,852 43,852
2015-04-21 Guenther Sven Exec VP R&D Conversion · Series A Convertible Preferred Stock −26,355 0
2015-04-21 Guenther Sven Exec VP R&D Conversion · Series B Convertible Preferred Stock −16,129 0
2015-04-21 Guenther Sven Exec VP R&D Conversion · Series C Convertible Preferred Stock −136,410 0
2015-04-15 Clifton R. LaDuane VP Fin & Corp Controller Grant or award · Stock Option (right to buy) +21,333 21,333

Page 25 of 25 · 499 trades